Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Steve Goodacre; Judith Cohen; Mike Bradburn; Alasdair Gray; Jonathan Benger; Timothy Coats

doi:10.1016/S2213-2600(13)70070-5

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Steve Goodacre, Judith Cohen, Mike Bradburn, Alasdair Gray, Jonathan Benger, Timothy Coats

Deanery of Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	293-300
Journal	The Lancet Respiratory Medicine
Volume	1
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(13)70070-5
Publication status	Published - 1 Jun 2013

Access to Document

10.1016/S2213-2600(13)70070-5

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma
Available under Open Access
Final published version, 229 KB

http://www.sciencedirect.com/science/article/pii/S2213260013700705

Cite this

@article{d1e297af6b0d4ebc95e768b0f265ccd1,

title = "Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial",

author = "Steve Goodacre and Judith Cohen and Mike Bradburn and Alasdair Gray and Jonathan Benger and Timothy Coats",

year = "2013",

month = jun,

day = "1",

doi = "10.1016/S2213-2600(13)70070-5",

language = "English",

volume = "1",

pages = "293--300",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "4",

}

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial. / Goodacre, Steve; Cohen, Judith; Bradburn, Mike; Gray, Alasdair; Benger, Jonathan; Coats, Timothy.

In: The Lancet Respiratory Medicine, Vol. 1, No. 4, 01.06.2013, p. 293-300.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

AU - Goodacre, Steve

AU - Cohen, Judith

AU - Bradburn, Mike

AU - Gray, Alasdair

AU - Benger, Jonathan

AU - Coats, Timothy

PY - 2013/6/1

Y1 - 2013/6/1

U2 - 10.1016/S2213-2600(13)70070-5

DO - 10.1016/S2213-2600(13)70070-5

M3 - Article

VL - 1

SP - 293

EP - 300

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

IS - 4

ER -